Sensurity Ltd

Back to portfolio

Sensurity is a radar intruder detection manufacturer. Sensurity’s products are technologically the most advanced in their class and have changed the paradigm of perimeter security.

99.9%

Probability of detection

5.8Ghz

Operating Frequency

200

Devices sold worldwide

Sensurity’s technology was developed at Queen’s University, Belfast, where a team of radio frequency experts developed unique patents in RF and digital signal processing to deliver the intelligence to differentiate between unauthorised intrusion events and false alarms.

Sensurity’s products are currently in 10 countries and distributed through a network of 16 partners worldwide.

Sensurity’s HALO is a Perimeter Intruder Detection System which uses intelligent radar signal analytics to increase detection rates to 99.9% probability, and drastically decrease false alarm rates.

HALO saves you time and money on responding to nuisance alarms, and gives you peace of mind and complete confidence in your perimeter security against malicious intruders.

HALO’s dual–technology radar and infrared units can be deployed back–to–back with no gaps or overlap, ensuring a fast, hassle free installation, saving you time and money on maintenance and saving space due to a reduced installation footprint.

Visit website
  • Digital, Engineering

    Embedded Monitoring Systems

    EMS design and manufacture innovative and cost–effective power monitoring systems for the electricity supply industry from Generation plants to Transmission and Distribution networks.

    Read more
  • Digital, Scientific

    Liopa Ltd

    Liopa develop automated lip reading software.

    Read more
  • Environmental, Engineering, Scientific

    MOF Technologies Ltd

    World leaders in the manufacture, testing and commercialisation of Metal Organic Frameworks; a new generation of adsorbents used in cleantech applications across the world.

    Read more
  • Life Science

    ProAxsis

    ProAxsis specialises in the development and commercialisation of in vitro diagnostic laboratory assays and point–of–care tests designed to measure active protease biomarkers of disease.

    Read more